RUSSO, SABINA
 Distribuzione geografica
Continente #
EU - Europa 360
NA - Nord America 318
AS - Asia 61
Totale 739
Nazione #
US - Stati Uniti d'America 316
IE - Irlanda 130
SE - Svezia 95
IT - Italia 62
CN - Cina 55
PL - Polonia 26
BE - Belgio 12
FI - Finlandia 10
UA - Ucraina 7
DE - Germania 6
GB - Regno Unito 4
VN - Vietnam 4
FR - Francia 3
CA - Canada 2
RU - Federazione Russa 2
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
JP - Giappone 1
TR - Turchia 1
Totale 739
Città #
Dublin 130
Chandler 92
Nyköping 53
Messina 36
Ann Arbor 35
Beijing 26
Warsaw 26
Jacksonville 23
Princeton 15
Medford 14
Brussels 12
Cambridge 12
Woodbridge 12
Des Moines 10
Wilmington 10
Dearborn 8
Hebei 6
Boardman 5
Falls Church 5
San Mateo 5
Cosenza 4
Dong Ket 4
Latina 4
Petrosino 4
Ashburn 3
Houston 3
Ningbo 3
Norwalk 3
Auburn Hills 2
Bremen 2
Crosia 2
Guangzhou 2
Hangzhou 2
Modica 2
Nanchang 2
Ottawa 2
Redwood City 2
Shenyang 2
Tianjin 2
Belvedere Spinello 1
El Paso 1
Fremont 1
Jinan 1
Lausanne 1
Los Angeles 1
Mascalucia 1
Nanjing 1
Noto 1
Puxian 1
Qingdao 1
Saint Petersburg 1
Seattle 1
Strasbourg 1
Taiyuan 1
Taizhou 1
Zaragoza 1
Zhengzhou 1
Totale 603
Nome #
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 100
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 72
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient. 71
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 68
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 68
Vaccination of multiple myeloma: Current strategies and future prospects 55
Vaccination strategies in lymphoproliferative disorders: Failures and successes 47
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 44
Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature 41
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 41
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 38
Standardisation of minimal residual disease in multiple myeloma 37
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 36
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 30
Global cardiovascular assessment in patients with PH+ chronic myeloid leukaemia treated with TKI: long-term follow-up 25
Totale 773
Categoria #
all - tutte 1530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201819 0000 00 00 40123
2018/20199 0012 21 00 1002
2019/202072 5121 211 83 223122
2020/2021146 1441611 2010 64 321577
2021/2022136 1837 55 1214 5301135
2022/2023326 26471534 1725 310 149000
Totale 773